home / stock / nvax / nvax quote
Last: | $4.71 |
---|---|
Change Percent: | -0.43% |
Open: | $4.69 |
Close: | $4.71 |
High: | $4.78 |
Low: | $4.6 |
Volume: | 3,649,868 |
Last Trade Date Time: | 05/02/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$4.71 | $4.69 | $4.71 | $4.78 | $4.6 | 3,649,868 | 05-02-2024 |
$4.67 | $4.3 | $4.67 | $4.8 | $4.29 | 5,382,449 | 05-01-2024 |
$4.33 | $4.27 | $4.33 | $4.48 | $4.25 | 4,280,884 | 04-30-2024 |
$4.29 | $4.14 | $4.29 | $4.32 | $4.1 | 3,900,486 | 04-29-2024 |
$4.09 | $3.97 | $4.09 | $4.13 | $3.92 | 3,021,805 | 04-26-2024 |
$3.95 | $4.09 | $3.95 | $4.12 | $3.9 | 3,380,674 | 04-25-2024 |
$4.15 | $4.26 | $4.15 | $4.26 | $4.1 | 2,441,473 | 04-24-2024 |
$4.19 | $4.09 | $4.19 | $4.36 | $4.08 | 3,577,496 | 04-23-2024 |
$4.07 | $3.99 | $4.07 | $4.13 | $3.91 | 2,302,021 | 04-22-2024 |
$3.97 | $3.89 | $3.97 | $4.0199 | $3.86 | 2,923,119 | 04-19-2024 |
$3.89 | $3.89 | $3.89 | $3.985 | $3.81 | 2,861,979 | 04-18-2024 |
$3.89 | $4 | $3.89 | $4.05 | $3.88 | 3,723,838 | 04-17-2024 |
$3.99 | $4.07 | $3.99 | $4.105 | $3.95 | 3,719,407 | 04-16-2024 |
$4.12 | $4.42 | $4.12 | $4.43 | $4.1 | 5,326,737 | 04-15-2024 |
$4.28 | $4.3 | $4.28 | $4.4773 | $4.24 | 4,008,108 | 04-12-2024 |
$4.3 | $4.34 | $4.3 | $4.3624 | $4.23 | 3,008,009 | 04-11-2024 |
$4.26 | $4.35 | $4.26 | $4.351 | $4.22 | 5,292,403 | 04-10-2024 |
$4.42 | $4.42 | $4.42 | $4.65 | $4.395 | 3,639,594 | 04-09-2024 |
$4.43 | $4.42 | $4.43 | $4.48 | $4.36 | 2,050,599 | 04-08-2024 |
$4.42 | $4.39 | $4.42 | $4.54 | $4.315 | 3,545,050 | 04-05-2024 |
News, Short Squeeze, Breakout and More Instantly...
2024-04-29 08:10:00 ET The market isn't rational always and everywhere. Sometimes, shares of excellent companies with bright futures almost inexplicably fail to keep pace with broader equities. When that happens, it's worth it to buy the dip. Other times, some corporations lag the market fo...
Believes the two new nominated directors possess the necessary experience to tackle the underperformance of the business which will improve its sh...
Believes the two new nominated directors possess the necessary experience to tackle the underperformance of the business which will improve its share price Shah Capital which owns 6.7% of Novavax, in a letter to the board says that the low share price reflects the board and management...